SearchDictionaryMobileLogin

Interleukin-1 beta- and tumour-necrosis-factor-induced inhibition of rat gastric fundus motility in vitro.

AbstractIn this study, we compared the effects of interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) on in vitro rat gastric fundus motility. IL-1 beta and TNF produced rapid, concentration-dependent relaxation of the rat gastric fundus strips with maximal effect at 300 pg ml-1 and 10 ng ml-1, and estimated EC50S at 10 and 450 pg ml-1, respectively. The relaxant effects of IL-1 beta and TNF were not influenced by the inhibition of cyclo-oxygenase or NO-synthase activities. IL-1 beta- and TNF-induced gastric relaxations were inhibited by BW 755c, which inhibits both cyclo-oxygenase and lipoxygenase (LO), BW A4c, which selectively inhibits the 5-LO pathway, and SC 41930, a selective leukotriene B4 (LTB4) receptor antagonist, providing pharmacological evidence that LTB4 is involved in the relaxant effects of both cytokines. The IL-1 beta- and TNF-induced activation of 5-LO pathway did not appear to be triggered by phospholipase A2. An alternative pathway could involve the activation of a phospholipase C, specific for phosphatidylcholine, from which, in sequence: the formation of diacylglycerol (DAG), DAG-induced activation of protein kinase C and the formation of free arachidonic acid from DAG would ensue. This mechanism is suggested by the finding that LTB4 is able to mimic cytokine-induced strip relaxation only in the presence of phorbol 12-myristate 13-acetate, which selectively activates protein kinase C.
AuthorsP Montuschi, G Tringali, L Parente, P Preziosi, P Navarra (Affiliation: Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy.)
JournalPharmacological research : the official journal of the Italian Pharmacological Society (Pharmacol Res) Vol. 30 Issue 1 Pg. 25-33 (Jul 1994) ISSN: 1043-6618 ENGLAND
PMID7831192 (Publication Type: In Vitro, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-1
  • Leukotrienes
  • Tumor Necrosis Factor-alpha
  • 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine
  • Type C Phospholipases
Topics
  • 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine (pharmacology)
  • Animals
  • Dose-Response Relationship, Drug
  • Female
  • Gastric Fundus (physiology)
  • Gastrointestinal Motility (drug effects)
  • Interleukin-1 (pharmacology)
  • Leukotrienes (physiology)
  • Male
  • Rats
  • Rats, Wistar
  • Tumor Necrosis Factor-alpha (pharmacology)
  • Type C Phospholipases (physiology)